HSBC Holdings
EBS icon

HSBC Holdings’s Emergent Biosolutions EBS Stock Holding History

HSBC Holdings’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,185
Closed -$160K – 2804
2025
Q2 		$160K Buy
25,185
+7,048
+39% +$40.3K ﹤0.01% 2746
2025
Q1 		$87.6K Sell
18,137
-590
-3% -$4.88K ﹤0.01% 2836
2024
Q4 		$178K Sell
18,727
-16,944
-48% -$155K ﹤0.01% 2753
2024
Q3 		$287K Sell
35,671
-52,008
-59% -$473K ﹤0.01% 2373
2024
Q2 		$614K Buy
87,679
+23,250
+36% +$100K ﹤0.01% 1877
2024
Q1 		$163K Sell
64,429
-72,228
-53% -$163K ﹤0.01% 2739
2023
Q4 		$326K Buy
136,657
+61,524
+82% +$145K ﹤0.01% 2240
2023
Q3 		$250K Buy
75,133
+56,129
+295% +$311K ﹤0.01% 2305
2023
Q2 		$140K Sell
19,004
-2,127
-10% -$19.7K ﹤0.01% 2388
2023
Q1 		$220K Sell
21,131
-6,715
-24% -$81.2K ﹤0.01% 2350
2022
Q4 		$321K Buy
+27,846
New +$431K ﹤0.01% 2503
2022
Q3 		– Sell
-16,053
Closed -$508K – 3007
2022
Q2 		$508K Sell
16,053
-4,116
-20% -$141K ﹤0.01% 2321
2022
Q1 		$841K Buy
20,169
+11,569
+135% +$510K ﹤0.01% 2071
2021
Q4 		$382K Buy
+8,600
New +$389K ﹤0.01% 2625
2021
Q1 		– Sell
-43,277
Closed -$3.88M – 2822
2020
Q4 		$3.88M Sell
43,277
-15,308
-26% -$1.4M 0.01% 1115
2020
Q3 		$6.06M Buy
58,585
+50,210
+600% +$5.41M 0.01% 884
2020
Q2 		$662K Buy
8,375
+683
+9% +$50.9K ﹤0.01% 1659
2020
Q1 		$445K Buy
+7,692
New +$443K ﹤0.01% 1840
2019
Q2 		– Sell
-4,435
Closed -$223K – 2723
2019
Q1 		$223K Buy
+4,435
New +$262K ﹤0.01% 2495

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HSBC Holdings's EBS Position: Q3 2025 in Review

HSBC Holdings sold out of Emergent Biosolutions (EBS) in Q3 2025, closing a stake of 25,185 shares — an estimated $160K sold.

HSBC Holdings first reported a position in EBS in Q1 2019 and held it in 19 quarters. The position peaked at $6.06M in Q3 2020. 169 funds tracked by Wall St. Rank hold EBS as of Q3 2025.

  • HSBC Holdings reported no remaining Emergent Biosolutions position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 25,185 Emergent Biosolutions shares in Q3 2025, an estimated $160K.
  • HSBC Holdings first reported a position in Emergent Biosolutions in Q1 2019 and held it in 19 quarters.
  • HSBC Holdings's Emergent Biosolutions position peaked at $6.06M in Q3 2020.
  • 169 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.